Shuji Sumida

Title: The Innovations of Shuji Sumida

Introduction

Shuji Sumida is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work focuses on developing innovative formulations that enhance the efficacy and stability of pharmaceutical agents.

Latest Patents

Among his latest patents is a formulation that is protein-free, which includes a stable granulocyte colony-stimulating factor. This formulation comprises a granulocyte colony-stimulating factor and at least one pharmaceutically acceptable surfactant in an amount of 1 part by weight or less per part by weight of the granulocyte colony-stimulating factor, maintaining a pH of 7 or less. Another notable patent is for a slow-release pharmaceutical agent that includes fumaric acid and/or DL-tryptophan, along with one or more pharmaceutically active substances. This agent is designed to extend the duration of release of pharmacologically active substances and can be formulated in various solid forms such as powder, granule, tablet, troche, capsule, or suppository.

Career Highlights

Shuji Sumida is currently associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His innovative work has positioned him as a key figure in the development of advanced pharmaceutical formulations.

Collaborations

He has collaborated with notable coworkers, including Yoshimitsu Iida and Takashi Terazono, contributing to the advancement of pharmaceutical technologies.

Conclusion

Shuji Sumida's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to enhancing drug formulations. His work continues to impact the industry positively, paving the way for future advancements in pharmaceutical science.